Assetmark Inc. decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 2.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 623,015 shares of the exchange traded fund’s stock after selling 12,828 shares during the quarter. Assetmark Inc. owned approximately 0.98% of SPDR S&P Biotech ETF worth $79,578,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Financial Life Planners acquired a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter worth $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $27,000. Intesa Sanpaolo Wealth Management acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth about $30,000. SHP Wealth Management acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth about $31,000. Finally, Legacy Wealth Managment LLC ID purchased a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth about $32,000.
SPDR S&P Biotech ETF Price Performance
SPDR S&P Biotech ETF stock opened at $152.00 on Friday. The company has a market cap of $10.34 billion, a price-to-earnings ratio of 11.47 and a beta of 0.82. SPDR S&P Biotech ETF has a 12 month low of $84.39 and a 12 month high of $165.71. The stock’s 50-day moving average is $142.06 and its 200-day moving average is $132.23.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
